Theramex beats guidance with strong uptake from existing lenders
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
LevFin

Theramex beats guidance with strong uptake from existing lenders

Oscar Laurikka
July 21, 2022 07:43 PM
"Evorel" Hormone or Estrogen replacement therapy (HRT) made by "Theramex" pharmaceutical company. Oestradiol trans dermal patch used during menopause

Finances drug company's buyout by Carlyle and PAI Partners

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Private EquityLevFin Leveraged LoansCorporate BondsHealth and Biotech
OL
Oscar Laurikka
GlobalCapital
Contact
Gift this article